Literature DB >> 3358991

Sample sizes based on the log-rank statistic in complex clinical trials.

E Lakatos1.   

Abstract

The log-rank test is frequently used to compare survival curves. While sample size estimation for comparison of binomial proportions has been adapted to typical clinical trial conditions such as noncompliance, lag time, and staggered entry, the estimation of sample size when the log-rank statistic is to be used has not been generalized to these types of clinical trial conditions. This paper presents a method of estimating sample sizes for the comparison of survival curves by the log-rank statistic in the presence of unrestricted rates of noncompliance, lag time, and so forth. The method applies to stratified trials in which the above conditions may vary across the different strata, and does not assume proportional hazards. Power and duration, as well as sample sizes, can be estimated. The method also produces estimates for binomial proportions and the Tarone-Ware class of statistics.

Mesh:

Year:  1988        PMID: 3358991

Source DB:  PubMed          Journal:  Biometrics        ISSN: 0006-341X            Impact factor:   2.571


  69 in total

1.  Design and analysis of clinical trials in the presence of delayed treatment effect.

Authors:  Tony Sit; Mengling Liu; Michael Shnaidman; Zhiliang Ying
Journal:  Stat Med       Date:  2016-02-02       Impact factor: 2.373

2.  Mutation Status of RAS, TP53, and SMAD4 is Superior to Mutation Status of RAS Alone for Predicting Prognosis after Resection of Colorectal Liver Metastases.

Authors:  Yoshikuni Kawaguchi; Scott Kopetz; Timothy E Newhook; Mario De Bellis; Yun Shin Chun; Ching-Wei D Tzeng; Thomas A Aloia; Jean-Nicolas Vauthey
Journal:  Clin Cancer Res       Date:  2019-06-20       Impact factor: 12.531

3.  Comparison of mid-term carcinologic control obtained after open, laparoscopic, and robot-assisted radical prostatectomy for localized prostate cancer.

Authors:  Sarah J Drouin; Christophe Vaessen; Vincent Hupertan; Eva Comperat; Vincent Misraï; Alain Haertig; Marc-Olivier Bitker; Emmanuel Chartier-Kastler; François Richard; Morgan Rouprêt
Journal:  World J Urol       Date:  2009-05-07       Impact factor: 4.226

4.  Optimal two-stage log-rank test for randomized phase II clinical trials.

Authors:  Minjung Kwak; Sin-Ho Jung
Journal:  J Biopharm Stat       Date:  2016-04-06       Impact factor: 1.051

5.  Estimating treatment effects with treatment switching via semicompeting risks models: an application to a colorectal cancer study.

Authors:  Donglin Zeng; Qingxia Chen; Ming-Hui Chen; Joseph G Ibrahim
Journal:  Biometrika       Date:  2011-12-29       Impact factor: 2.445

6.  Improved design of prodromal Alzheimer's disease trials through cohort enrichment and surrogate endpoints.

Authors:  Eric A Macklin; Deborah Blacker; Bradley T Hyman; Rebecca A Betensky
Journal:  J Alzheimers Dis       Date:  2013       Impact factor: 4.472

7.  Power of the Mantel-Haenszel and other tests for discrete or grouped time-to-event data under a chained binomial model.

Authors:  John M Lachin
Journal:  Stat Med       Date:  2012-07-16       Impact factor: 2.373

8.  Design and rationale of a multicenter defeat alcoholic steatohepatitis trial: (DASH) randomized clinical trial to treat alcohol-associated hepatitis.

Authors:  Srinivasan Dasarathy; Mack C Mitchell; Bruce Barton; Craig J McClain; Gyongyi Szabo; Laura E Nagy; Svetlana Radaeva; Arthur J McCullough
Journal:  Contemp Clin Trials       Date:  2020-07-31       Impact factor: 2.226

9.  IMPROVE trial: a randomized controlled trial of patient-controlled analgesia for sickle cell painful episodes: rationale, design challenges, initial experience, and recommendations for future studies.

Authors:  Carlton D Dampier; Wally R Smith; Carrie G Wager; Hae-Young Kim; Margaret C Bell; Scott T Miller; Debra L Weiner; Caterina P Minniti; Lakshmanan Krishnamurti; Kenneth I Ataga; James R Eckman; Lewis L Hsu; Donna McClish; Sonja M McKinlay; Robert Molokie; Ifeyinwa Osunkwo; Kim Smith-Whitley; Marilyn J Telen
Journal:  Clin Trials       Date:  2013-04       Impact factor: 2.486

10.  Delirium in hospitalized elderly patients and post-discharge mortality.

Authors:  Danielle Pessoa Lima; Marcelo Eidi Ochiai; Alexandre Bastos Lima; Jose A E Curiati; Jose M Farfel; Wilson Jacob Filho
Journal:  Clinics (Sao Paulo)       Date:  2010-03       Impact factor: 2.365

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.